Fri, September 30, 2016

by: WOPRAI

Karen Chan Maintained (WB) at Strong Buy with Increased Target to $60 on, Sep 30th, 2016

by: WOPRAI

Michael Baudendistel Maintained (TRN) at Hold with Increased Target to $21 on, Sep 30th, 2016

by: WOPRAI

Michael Lasser Maintained (TSCO) at Strong Buy with Decreased Target to $80 on, Sep 30th, 2016

by: WOPRAI

Stephen Gengaro Initiated (TS) at Hold and Held Target at $28 on, Sep 30th, 2016

by: WOPRAI

Jay Gelb Maintained (TRV) at Hold with Increased Target to $109 on, Sep 30th, 2016

by: WOPRAI

Barrett Blaschke Initiated (SUN) at Hold on, Sep 30th, 2016

by: WOPRAI

Adam Samuelson Maintained (SYY) at Hold with Decreased Target to $50 on, Sep 30th, 2016

by: WOPRAI

Stephen Gengaro Initiated (TTI) at Strong Buy and Held Target at $9 on, Sep 30th, 2016

by: WOPRAI

Arun Viswanathan Initiated (CCK) at Buy and Held Target at $65 on, Sep 30th, 2016

by: WOPRAI

Aldo Mazzaferro Maintained (WOR) at Hold with Increased Target to $35 on, Sep 30th, 2016

by: WOPRAI

Robert Drbul Initiated (WMT) at Strong Buy on, Sep 30th, 2016

by: WOPRAI

Christopher Mandeville Maintained (UNFI) at Hold with Decreased Target to $44 on, Sep 30th, 2016

by: WOPRAI

Ralph Giacobbe Maintained (UHS) at Hold with Decreased Target to $131 on, Sep 30th, 2016

by: WOPRAI

Robert Drbul Initiated (TGT) at Hold on, Sep 30th, 2016

by: WOPRAI

Christopher Mandeville Maintained (SPTN) at Hold with Decreased Target to $27 on, Sep 30th, 2016

by: WOPRAI

Jay Gelb Maintained (ALL) at Buy with Increased Target to $79 on, Sep 30th, 2016

by: WOPRAI

Cynthia Motz Initiated (AYI) at Strong Buy and Held Target at $306 on, Sep 30th, 2016

by: WOPRAI

Jim Suva Maintained (AAPL) at Strong Buy with Increased Target to $33 on, Sep 30th, 2016

by: WOPRAI

Robert Drbul Initiated (VFC) at Strong Buy on, Sep 30th, 2016

by: WOPRAI

Munjal Shah Maintained (ACN) at Hold with Increased Target to $125 on, Sep 30th, 2016

by: WOPRAI

Ashwin Shirvaikar Maintained (ACN) at Hold with Increased Target to $120 on, Sep 30th, 2016

by: WOPRAI

Darrin Peller Maintained (ACN) at Hold with Increased Target to $128 on, Sep 30th, 2016

by: WOPRAI

Donald Ellis Initiated (ACRS) at Hold on, Sep 30th, 2016

by: WOPRAI

Colin Isaac Upgraded (APD) to Hold on, Sep 30th, 2016

by: WOPRAI

Jay Gelb Maintained (AON) at Hold with Increased Target to $104 on, Sep 30th, 2016

by: WOPRAI

Robert Drbul Initiated (AMZN) at Strong Buy on, Sep 30th, 2016

by: WOPRAI

Jay Gelb Maintained (AJG) at Buy with Increased Target to $56 on, Sep 30th, 2016

by: WOPRAI

Christopher Mandeville Upgraded (CASY) to Strong Buy on, Sep 30th, 2016

Thu, September 29, 2016

by: WOPRAI

Market Maker Surveillance Report. KMI, WFT, WLL, HIMX, UVXY, ZNGA, Bullishly Biased Price Friction For Thursday, September 29t

by: WOPRAI

Market Maker Surveillance Report. ATLS, FAC, AREX, MRUS, TAT, XXII, Winning Stocks With Lowest Price Friction For Thursday, Se

by: WOPRAI

Market Maker Surveillance Report. THLD, INVT, ITCI, GLPW, RGSE, MRNS, Losing Stocks With Lowest Price Friction For Thursday, S

by: WOPRAI

Market Maker Surveillance Report. MT, CHK, DNR, YHOO, GDX, JNK, Bearishly Biased Price Friction For Thursday, September 29th 2

by: WOPRAI

Market Maker Surveillance Report. SPY, PFE, SXL, GE, SIRI, JD, Highest Net Sell Volume and Negative Price Friction For Thursda

by: WOPRAI

Market Maker Surveillance Report. MU, MBG, MPW, USO, WPX, DGAZ, Highest Net Buy Volume With Lowest Price Friction For Thursday

by: WOPRAI

GEL SqueezeTrigger Price is $37.02. There is $88,257,972 That Short Sellers Still Need To Cover.

by: WOPRAI

Seattle Genetics, Inc. (NASDAQ:SGEN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

Xerium Technologies Inc. (NYSE:XRM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In O

by: WOPRAI

Skyline Corp (NYSE:SKY), Up By $2.94 (28.70%) After BUYINS.NET SqueezeTrigger Report Released on Monday, August 22nd 2016 at a

by: WOPRAI

United Therapeutics Corporation (NASDAQ:UTHR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Out

by: WOPRAI

bluebird bio Inc. (NASDAQ:BLUE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our R

by: WOPRAI

Pluristem Therapeutics Inc. (NASDAQ:PSTI), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outline

by: WOPRAI

Spark Therapeutics Inc. (NASDAQ:ONCE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

Alimera Sciences Inc. (NASDAQ:ALIM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In O

by: WOPRAI

FibroGen Inc. (NASDAQ:FGEN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

Aduro Biotech Inc. (NASDAQ:ADRO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

Lion Biotechnologies Inc. (NASDAQ:LBIO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

Xencor (NASDAQ:XNCR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

NHTC SqueezeTrigger Price is $29.57. There is $86,234,838 That Short Sellers Still Need To Cover.

Jay Gelb Maintained (TRV) at Hold with Increased Target to $109 on, Sep 30th, 2016

Jay Gelb of Barclays, Maintained "The Travelers Companies, Inc." (TRV) at Hold with Increased Target from $105 to $109 on, Sep 30th, 2016.

Jay has made no other calls on TRV in the last 4 months.



There is 1 other peer that has a rating on TRV. Out of the 1 peers that are also analyzing TRV, 0 agree with Jay's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jay

  • Joshua Shanker of "B of A Securities" Upgraded from Hold to Strong Buy on, Tuesday, June 28th, 2016